ACM Research Shanghai Inc
SSE:688082
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
92.6
201.8
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Wall Street
Price Targets
Price Targets Summary
ACM Research Shanghai Inc
According to Wall Street analysts, the average 1-year price target for
ACM Research Shanghai Inc
is 200.66 CNY
with a low forecast of 119.37 CNY and a high forecast of 262.5 CNY.
Operating Income
Forecast
Operating Income Estimate
ACM Research Shanghai Inc
For the last 5 years the
compound annual growth rate for
ACM Research Shanghai Inc's operating income is
52%.
The projected
CAGR
for the next 3 years is
35%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ACM Research Shanghai Inc's stock price target?
Price Target
200.66
CNY
According to Wall Street analysts, the average 1-year price target for
ACM Research Shanghai Inc
is 200.66 CNY
with a low forecast of 119.37 CNY and a high forecast of 262.5 CNY.
What is ACM Research Shanghai Inc's Revenue forecast?
Projected CAGR
28%
For the last 5 years the
compound annual growth rate for
ACM Research Shanghai Inc's revenue is
49%.
The projected
CAGR
for the next 3 years is
28%.
What is ACM Research Shanghai Inc's Operating Income forecast?
Projected CAGR
35%
For the last 5 years the
compound annual growth rate for
ACM Research Shanghai Inc's operating income is
52%.
The projected
CAGR
for the next 3 years is
35%.
What is ACM Research Shanghai Inc's Net Income forecast?
Projected CAGR
36%
For the last 5 years the
compound annual growth rate for
ACM Research Shanghai Inc's net income is
54%.
The projected
CAGR
for the next 3 years is
36%.